Id |
Subject |
Object |
Predicate |
Lexical cue |
T25 |
6-7 |
-LRB- |
denotes |
( |
T26 |
7-11 |
NNS |
denotes |
CoVs |
T27 |
11-12 |
-RRB- |
denotes |
) |
T28 |
13-16 |
VBP |
denotes |
are |
T29 |
17-25 |
JJ |
denotes |
zoonotic |
T30 |
26-35 |
NNS |
denotes |
pathogens |
T31 |
36-40 |
IN |
denotes |
with |
T32 |
41-45 |
JJ |
denotes |
high |
T33 |
46-54 |
NN |
denotes |
fatality |
T34 |
55-60 |
NNS |
denotes |
rates |
T35 |
61-64 |
CC |
denotes |
and |
T36 |
65-73 |
JJ |
denotes |
pandemic |
T37 |
74-83 |
NN |
denotes |
potential |
T38 |
85-92 |
NN |
denotes |
Vaccine |
T39 |
93-104 |
NN |
denotes |
development |
T40 |
105-112 |
VBZ |
denotes |
focuses |
T41 |
113-115 |
IN |
denotes |
on |
T42 |
116-119 |
DT |
denotes |
the |
T43 |
120-129 |
JJ |
denotes |
principal |
T44 |
130-136 |
NN |
denotes |
target |
T45 |
137-139 |
IN |
denotes |
of |
T46 |
140-143 |
DT |
denotes |
the |
T47 |
144-156 |
VBG |
denotes |
neutralizing |
T48 |
157-164 |
JJ |
denotes |
humoral |
T49 |
165-171 |
JJ |
denotes |
immune |
T50 |
172-180 |
NN |
denotes |
response |
T51 |
180-181 |
-COMMA- |
denotes |
, |
T52 |
182-185 |
DT |
denotes |
the |
T53 |
186-191 |
NN |
denotes |
spike |
T54 |
192-193 |
-LRB- |
denotes |
( |
T55 |
193-194 |
NN |
denotes |
S |
T56 |
194-195 |
-RRB- |
denotes |
) |
T57 |
196-208 |
NN |
denotes |
glycoprotein |
T58 |
210-221 |
NN |
denotes |
Coronavirus |
T59 |
222-223 |
NN |
denotes |
S |
T60 |
224-232 |
NNS |
denotes |
proteins |
T61 |
233-236 |
VBP |
denotes |
are |
T62 |
237-248 |
RB |
denotes |
extensively |
T63 |
249-261 |
VBN |
denotes |
glycosylated |
T64 |
261-262 |
-COMMA- |
denotes |
, |
T65 |
263-271 |
VBG |
denotes |
encoding |
T66 |
272-278 |
IN |
denotes |
around |
T67 |
279-284 |
CD |
denotes |
66–87 |
T68 |
285-293 |
JJ |
denotes |
N-linked |
T69 |
294-307 |
NN |
denotes |
glycosylation |
T70 |
308-313 |
NNS |
denotes |
sites |
T71 |
314-317 |
IN |
denotes |
per |
T72 |
318-326 |
JJ |
denotes |
trimeric |
T73 |
327-332 |
NN |
denotes |
spike |
T74 |
334-338 |
RB |
denotes |
Here |
T75 |
338-339 |
-COMMA- |
denotes |
, |
T76 |
340-342 |
PRP |
denotes |
we |
T77 |
343-349 |
VBP |
denotes |
reveal |
T78 |
350-351 |
DT |
denotes |
a |
T79 |
352-360 |
JJ |
denotes |
specific |
T80 |
361-365 |
NN |
denotes |
area |
T81 |
366-368 |
IN |
denotes |
of |
T82 |
369-373 |
JJ |
denotes |
high |
T83 |
374-380 |
NN |
denotes |
glycan |
T84 |
381-388 |
NN |
denotes |
density |
T85 |
389-391 |
IN |
denotes |
on |
T86 |
392-396 |
NNP |
denotes |
MERS |
T87 |
397-398 |
NNP |
denotes |
S |
T88 |
399-403 |
WDT |
denotes |
that |
T89 |
404-411 |
VBZ |
denotes |
results |
T90 |
412-414 |
IN |
denotes |
in |
T91 |
415-418 |
DT |
denotes |
the |
T92 |
419-428 |
NN |
denotes |
formation |
T93 |
429-431 |
IN |
denotes |
of |
R23 |
T26 |
T25 |
arg2Of |
CoVs,( |
R24 |
T27 |
T25 |
arg3Of |
),( |
R26 |
T30 |
T28 |
arg2Of |
pathogens,are |
R27 |
T30 |
T29 |
arg1Of |
pathogens,zoonotic |
R28 |
T30 |
T31 |
arg1Of |
pathogens,with |
R29 |
T35 |
T31 |
arg2Of |
and,with |
R30 |
T34 |
T32 |
arg1Of |
rates,high |
R31 |
T34 |
T33 |
arg1Of |
rates,fatality |
R32 |
T34 |
T35 |
arg1Of |
rates,and |
R33 |
T37 |
T35 |
arg2Of |
potential,and |
R34 |
T37 |
T36 |
arg1Of |
potential,pandemic |
R35 |
T39 |
T38 |
arg1Of |
development,Vaccine |
R36 |
T39 |
T40 |
arg1Of |
development,focuses |
R37 |
T40 |
T41 |
arg1Of |
focuses,on |
R38 |
T44 |
T41 |
arg2Of |
target,on |
R39 |
T44 |
T42 |
arg1Of |
target,the |
R40 |
T44 |
T43 |
arg1Of |
target,principal |
R41 |
T44 |
T45 |
arg1Of |
target,of |
R42 |
T50 |
T45 |
arg2Of |
response,of |
R43 |
T50 |
T46 |
arg1Of |
response,the |
R44 |
T50 |
T47 |
arg1Of |
response,neutralizing |
R45 |
T50 |
T48 |
arg1Of |
response,humoral |
R46 |
T50 |
T49 |
arg1Of |
response,immune |
R47 |
T50 |
T51 |
arg1Of |
response,"," |
R48 |
T57 |
T51 |
arg2Of |
glycoprotein,"," |
R49 |
T57 |
T52 |
arg1Of |
glycoprotein,the |
R50 |
T57 |
T53 |
arg1Of |
glycoprotein,spike |
R51 |
T53 |
T54 |
arg1Of |
spike,( |
R52 |
T55 |
T54 |
arg2Of |
S,( |
R53 |
T56 |
T54 |
arg3Of |
),( |
R54 |
T60 |
T58 |
arg1Of |
proteins,Coronavirus |
R55 |
T60 |
T59 |
arg1Of |
proteins,S |
R56 |
T60 |
T61 |
arg1Of |
proteins,are |
R57 |
T63 |
T61 |
arg2Of |
glycosylated,are |
R58 |
T63 |
T62 |
arg1Of |
glycosylated,extensively |
R59 |
T60 |
T63 |
arg2Of |
proteins,glycosylated |
R60 |
T63 |
T64 |
arg1Of |
glycosylated,"," |
R61 |
T60 |
T65 |
arg1Of |
proteins,encoding |
R62 |
T70 |
T65 |
arg2Of |
sites,encoding |
R63 |
T63 |
T65 |
modOf |
glycosylated,encoding |
R64 |
T70 |
T66 |
arg1Of |
sites,around |
R65 |
T70 |
T67 |
arg1Of |
sites,66–87 |
R66 |
T70 |
T68 |
arg1Of |
sites,N-linked |
R67 |
T70 |
T69 |
arg1Of |
sites,glycosylation |
R68 |
T70 |
T71 |
arg1Of |
sites,per |
R69 |
T73 |
T71 |
arg2Of |
spike,per |
R70 |
T73 |
T72 |
arg1Of |
spike,trimeric |
R71 |
T77 |
T74 |
arg1Of |
reveal,Here |
R72 |
T77 |
T75 |
arg1Of |
reveal,"," |
R73 |
T76 |
T77 |
arg1Of |
we,reveal |
R74 |
T80 |
T77 |
arg2Of |
area,reveal |
R75 |
T80 |
T78 |
arg1Of |
area,a |
R76 |
T80 |
T79 |
arg1Of |
area,specific |
R77 |
T80 |
T81 |
arg1Of |
area,of |
R78 |
T84 |
T81 |
arg2Of |
density,of |
R79 |
T84 |
T82 |
arg1Of |
density,high |
R80 |
T84 |
T83 |
arg1Of |
density,glycan |
R81 |
T80 |
T85 |
arg1Of |
area,on |
R82 |
T87 |
T85 |
arg2Of |
S,on |
R83 |
T87 |
T86 |
arg1Of |
S,MERS |
R84 |
T80 |
T88 |
arg1Of |
area,that |
R85 |
T80 |
T89 |
arg1Of |
area,results |
R86 |
T89 |
T90 |
arg1Of |
results,in |
R87 |
T92 |
T90 |
arg2Of |
formation,in |
R88 |
T92 |
T91 |
arg1Of |
formation,the |
R89 |
T92 |
T93 |
arg1Of |
formation,of |